SLS BIO Co., Ltd (KOSDAQ:246250)
1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025
SLS BIO Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '15 Dec 31, 2015 |
Cash & Equivalents | 278.49 | 1,144 | 1,822 | 1,527 | 464.33 |
Short-Term Investments | 3,046 | 6,536 | 7,533 | 1,021 | 1,502 |
Cash & Short-Term Investments | 3,324 | 7,680 | 9,355 | 2,548 | 1,966 |
Cash Growth | -56.72% | -17.90% | 267.16% | 29.58% | 2514.23% |
Accounts Receivable | 616.71 | 1,786 | 1,982 | 3,029 | 3,004 |
Other Receivables | 68.47 | 46.06 | 66.78 | 5.35 | 10.55 |
Receivables | 685.18 | 1,833 | 2,049 | 3,034 | 3,023 |
Inventory | 172.02 | 173.37 | 260.85 | 307.2 | - |
Prepaid Expenses | 23.34 | 56.47 | 57.19 | 3.22 | 1.78 |
Other Current Assets | 309.99 | 46.47 | 28.67 | 166.03 | 88.93 |
Total Current Assets | 4,515 | 9,789 | 11,751 | 6,058 | 5,080 |
Property, Plant & Equipment | 4,390 | 4,740 | 4,173 | 4,084 | 1,417 |
Long-Term Investments | - | - | - | 42.14 | 64.12 |
Other Intangible Assets | 149.42 | 156.16 | 251.83 | 165.78 | 52.02 |
Long-Term Accounts Receivable | -0 | 0 | -0 | 123.78 | 0 |
Long-Term Deferred Tax Assets | 1,683 | 1,214 | 1,237 | 849.52 | 351.41 |
Long-Term Deferred Charges | - | - | - | - | 3,797 |
Other Long-Term Assets | 492.14 | 459.74 | 425.37 | 429.66 | 245.33 |
Total Assets | 11,229 | 16,359 | 17,838 | 11,753 | 11,007 |
Accounts Payable | 165.05 | 408.84 | 693.41 | 353.82 | 320.4 |
Accrued Expenses | 51.84 | 77.74 | 67.86 | 193.79 | 70.25 |
Short-Term Debt | - | - | - | - | 2,522 |
Current Portion of Long-Term Debt | - | - | - | - | 37.76 |
Current Portion of Leases | 626.66 | 561.43 | 568.26 | 565.64 | 121.64 |
Current Income Taxes Payable | - | - | - | - | 0.42 |
Other Current Liabilities | 740.46 | 426.44 | 406.21 | 930.14 | 949.51 |
Total Current Liabilities | 1,584 | 1,474 | 1,736 | 2,043 | 4,022 |
Long-Term Debt | - | - | - | - | 1,357 |
Long-Term Leases | 686.91 | 1,149 | 1,536 | 1,951 | 72.49 |
Pension & Post-Retirement Benefits | 1,154 | 1,141 | 1,021 | 977.72 | 574.16 |
Other Long-Term Liabilities | 169.12 | 81.56 | 78.52 | 75.26 | 0 |
Total Liabilities | 3,594 | 3,845 | 4,371 | 5,048 | 6,025 |
Common Stock | 7,674 | 7,674 | 3,837 | 3,433 | 2,889 |
Additional Paid-In Capital | 1,290 | 1,290 | 5,155 | 201.8 | 3,137 |
Retained Earnings | -642.56 | 4,261 | 4,309 | 2,884 | -997.37 |
Treasury Stock | -899.88 | -899.88 | - | - | - |
Comprehensive Income & Other | 213.35 | 187.61 | 164.95 | 186.67 | -46.97 |
Shareholders' Equity | 7,635 | 12,513 | 13,466 | 6,705 | 4,982 |
Total Liabilities & Equity | 11,229 | 16,359 | 17,838 | 11,753 | 11,007 |
Total Debt | 1,314 | 1,710 | 2,105 | 2,517 | 4,111 |
Net Cash (Debt) | 2,010 | 5,970 | 7,250 | 30.98 | -2,144 |
Net Cash Growth | -66.33% | -17.66% | 23304.74% | - | - |
Net Cash Per Share | 133.65 | 391.34 | 1030.67 | 4.52 | -430.00 |
Filing Date Shares Outstanding | 15.03 | 15.05 | 15.35 | 6.81 | 4.99 |
Total Common Shares Outstanding | 15.03 | 15.05 | 15.35 | 6.81 | 4.99 |
Working Capital | 2,931 | 8,315 | 10,015 | 4,015 | 1,058 |
Book Value Per Share | 508.13 | 831.55 | 877.38 | 983.97 | 998.93 |
Tangible Book Value | 7,486 | 12,357 | 13,214 | 6,539 | 4,930 |
Tangible Book Value Per Share | 498.19 | 821.17 | 860.97 | 959.64 | 988.50 |
Machinery | 2,613 | 2,659 | 2,586 | 2,501 | 638.3 |
Construction In Progress | 50.49 | 749.57 | 113.61 | 71.17 | 70.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.